The putative mechanisms underlying testosterone and cardiovascular risk.

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Men's Health

Background:

• Testosterone supplementation therapy (TST) use is increasing, particularly in men with symptomatic hypogonadism.
• While TST offers benefits, its impact on cardiovascular health requires careful evaluation due to conflicting evidence.
• Previous studies indicated no cardiovascular risks, but recent research suggests a potential association.

Purpose of the Study:

• To explore the role of TST in cardiovascular health.
• To elucidate the mechanisms by which TST might contribute to cardiovascular risk.
• To synthesize current understanding of TST's cardiovascular implications.

Main Methods:

• Review of existing literature on TST and cardiovascular outcomes.
• Analysis of proposed biological mechanisms linking TST to cardiovascular risk.
• Synthesis of evidence from previous and recent studies.

Main Results:

• Conflicting evidence exists regarding TST's cardiovascular safety.
• Several potential mechanisms for TST-induced cardiovascular risk have been proposed.
• These mechanisms include effects on thromboxane A2, vascular adhesion molecule 1, erythropoiesis, and sleep apnea, potentially leading to atherogenesis.

Conclusions:

• The precise cardiovascular risks associated with TST remain unclear.
• Further research is needed to fully understand and validate the proposed mechanisms.
• Clarifying these mechanisms is crucial for guiding safe TST prescription and patient management.